Financial results - SEYGYN CLINIQUE SRL

Financial Summary - Seygyn Clinique Srl
Unique identification code: 36567406
Registration number: J01/830/2016
Nace: 8622
Sales - Ron
256.328
Net Profit - Ron
187.775
Employee
1
The most important financial indicators for the company Seygyn Clinique Srl - Unique Identification Number 36567406: sales in 2023 was 256.328 euro, registering a net profit of 187.775 euro and having an average number of 1 employees. Firma isi desfasoara activitatea in domeniul Activitati de asistenta medicala specializata having the NACE code 8622.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Seygyn Clinique Srl

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR - - 2.418 5.086 9.088 36.219 194.032 153.885 154.507 256.328
Total Income - EUR - - 2.418 5.086 9.088 36.219 194.032 153.948 154.523 258.247
Total Expenses - EUR - - 0 1.102 803 11.496 97.191 53.171 104.479 68.216
Gross Profit/Loss - EUR - - 2.418 3.984 8.285 24.722 96.841 100.777 50.044 190.031
Net Profit/Loss - EUR - - 2.345 3.831 8.013 24.038 95.242 99.269 48.534 187.775
Employees - - 0 0 0 1 1 1 1 1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales increased by 66.4%, from 154.507 euro in the year 2022, to 256.328 euro in 2023. The Net Profit increased by 139.388 euro, from 48.534 euro in 2022, to 187.775 in the last year.

Check the financial reports for the company - Seygyn Clinique Srl

Rating financiar

Financial Rating -
Seygyn Clinique Srl

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Seygyn Clinique Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Seygyn Clinique Srl

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Seygyn Clinique Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Seygyn Clinique Srl - CUI 36567406

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets - - 96 95 93 36.445 40.471 39.300 66.804 331.655
Current Assets - - 2.488 6.235 11.830 14.928 128.830 73.275 83.219 312.163
Inventories - - 25 0 0 197 245 663 371 0
Receivables - - 1.410 929 7.163 4.478 584 111 68.537 288.662
Cash - - 1.052 5.306 4.667 10.254 128.001 72.501 14.311 23.501
Shareholders Funds - - 2.390 6.180 11.816 26.753 121.487 106.501 48.583 195.356
Social Capital - - 45 44 43 42 41 40 41 40
Debts - - 194 149 107 24.620 47.814 6.073 101.440 276.649
Income in Advance - - 0 0 0 0 0 0 0 171.813
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "8622 - 8622"
CAEN Financial Year 8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 312.163 euro in 2023 which includes Inventories of 0 euro, Receivables of 288.662 euro and cash availability of 23.501 euro.
The company's Equity was valued at 195.356 euro, while total Liabilities amounted to 276.649 euro. Equity increased by 146.921 euro, from 48.583 euro in 2022, to 195.356 in 2023. The Debt Ratio was 43.0% in the year 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Seygyn Clinique Srl

Comments - Seygyn Clinique Srl

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.